Company intelligence / Profile preview

OCT Clinical

Ownership
Private
Employees
~92
Development stage
Other
01

Overview

Since its founding in 2005, OCT Clinical has managed over 300 clinical trials across Eastern Europe and the CIS region. The company has built expertise in oncology and infectious diseases among other areas. In recent years it was principal CRO for large-scale COVID vaccine studies and consistently ranked among top regional CROs by trial volume. In May/June of 2024 it merged with Germany-based Palleos Healthcare to form an expanded European CRO under the Palleos brand.

Example result from their portfolio includes successful management of complex neonatal respiratory distress syndrome drug studies leading to marketing authorization.

The company does not develop its own drugs but provides full-service clinical trial management for pharma/biotech sponsors.

Recent projects include COVID vaccine trials for CanSino Biologics Inc., as well as work with Handok Inc., Stayble Therapeutics, Futura Medical, Recbio and others.

Therapeutic areas
OncologyRheumatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities
Small moleculeBiologicVaccine
Industry
Contract Research Organization
02

Partnerships

CanSino Biologics Inc.Handok Inc.Stayble TherapeuticsFutura MedicalRecbioPalleos Healthcare

Beyond the preview

Go deeper on OCT Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OCT Clinical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call